Drug Profile
Pirfenidone inhalation - Avalyn Pharmaceuticals
Alternative Names: Aerodone; AP 01; GP 101Latest Information Update: 29 Sep 2023
Price :
$50
*
At a glance
- Originator Avalyn Pharma
- Class Anti-inflammatories; Antifibrotics; Heart failure therapies; Pyridones; Small molecules
- Mechanism of Action Collagen inhibitors; Cytokine inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Phase II Idiopathic pulmonary fibrosis; Interstitial lung diseases
Most Recent Events
- 27 Sep 2023 Avalyn Pharma plans a phase IIb trial for Idiopathic pulmonary fibrosis
- 12 Sep 2023 Efficacy and adverse event data from the phase II AP01-005 trial in Interstitial lung diseases and Idiopathic pulmonary fibrosis released by Avalyn Pharma
- 23 May 2023 Adverse events data from a phase II trial in idiopathic pulmonary fibrosis released by Avalyn Pharma